Description
PRINCIPIO ACTIVO: KETOTIFENO
Características de BLUGAT:
un inhibidor de CDK4/6 indicado para el tratamiento del cáncer de mama avanzado o metastásico con receptores hormonales positivos (HR+) y HER2 negativo
5 ML | Inyección | 1 Jeringa Prellenada | Novartis
SUSTANCIA: UNNUS 40 POMADA CAJA C/TUBO C/45 G
SURGAM 300 MG 30 CPR DEXKETOPROFENO PRINCIPIO ACTIVO: KETOTIFENOPRINCIPIO ACTIVO: ACIDO TIAPROFENICO DOSIS: 300 MG FORMA FARMACUTICA: 30 COMPRIMIDOS PRESENTACIN: 1 CAJA
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
recommand products
![[FD0791-012] Mens Nike ZOOM VOMERO 5 'IRON ORE FLAT PEWTER' Pants](https://cdn.shopify.com/s/files/1/0013/0164/3322/files/FD0791_012_A_PREM.jpg?v=1687620112)
![[DH4677-200] Mens Nike AIR MAX 90 TERRASCAPE 'RATTAN BLACK' Gender_Crib](https://cdn.shopify.com/s/files/1/0013/0164/3322/files/DH4677_200_A_PREM.jpg?v=1687621307)
